RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
Robert J. Nichols(Revolution Medicines (United States)), Franziska Haderk(University of California, San Francisco), Carlos Stahlhut(Revolution Medicines (United States)), Christopher J. Schulze(Revolution Medicines (United States)), Golzar Hemmati(University of California, San Francisco), David Wildes(Revolution Medicines (United States)), Christos Tzitzilonis(Revolution Medicines (United States)), Kasia Mordec(Revolution Medicines (United States)), Abby Marquez(Revolution Medicines (United States)), Jason M. Romero(Revolution Medicines (United States)), Tientien Hsieh(Revolution Medicines (United States)), Aubhishek Zaman(University of California, San Francisco), Victor Olivas(University of California, San Francisco), Caroline E. McCoach(University of California, San Francisco), Collin M. Blakely(University of California, San Francisco), Zhengping Wang(Revolution Medicines (United States)), Gert Kiss(Revolution Medicines (United States)), Elena S. Koltun(Revolution Medicines (United States)), Adrian L. Gill(Revolution Medicines (United States)), Mallika Singh(Revolution Medicines (United States)), Mark A. Goldsmith(Revolution Medicines (United States)), Jacqueline A.M. Smith(Revolution Medicines (United States)), Trever G. Bivona(University of California, San Francisco)
Cited by 414
Abstract
Related Papers
No related papers found
Powered by citation graph analysis